BeOne: Brukinsa Sets CLL Standard with 78-Month Data at ASCO
29 May 2026 //
BUSINESSWIRE
FDA Approves Blood Cancer Drugs From Beone And Taiho
15 May 2026 //
REUTERS
BeOne Wins Mantle Cell Lymphoma Approval
14 May 2026 //
BIOSPACE
29 May 2026 //
BUSINESSWIRE
15 May 2026 //
REUTERS
14 May 2026 //
BIOSPACE
Market Place
Sourcing Support